|
|
| (9 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | {{pnc}} | | {{pnc}} |
| | + | {{ft|X}} |
| | *'''[[Diagnosis (Laboratory other parameters)]]''' | | *'''[[Diagnosis (Laboratory other parameters)]]''' |
| | + | *'''[[Dx multi-virus]]''' |
| | *'''[[Dx PCR]]''' | | *'''[[Dx PCR]]''' |
| | *'''[[Dx Antigen]]''' | | *'''[[Dx Antigen]]''' |
| Zeile 10: |
Zeile 12: |
| | | | |
| | ---- | | ---- |
| − | {{tp|p=32077933|t=ä. ...Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32353116|t=ä. Modeling SARS-CoV-2 positivity using laboratory data: timing is everything |pdf=|usr=}}
| |
| − | {{tp|p=32306042|t=ä. Testing for SARS-CoV-2: Can We Stop at Two?|pdf=|usr=}}
| |
| − | {{tp|p=32156101|t=2020. Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32361322|t=2020. Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus |pdf=|usr=}}
| |
| − | {{tp|p=32378843|t=2020. Akutt lungesviktsyndrom hos covid-19-pasient med negative nasofarynksprover |pdf=|usr=}}
| |
| − | {{tp|p=32403009|t=2020. Five-minute point-of-care testing for SARS-CoV-2: Not there yet |pdf=|usr=}}
| |
| − | {{tp|p=32372836|t=2020. The problems with so-called immunity tests |pdf=|usr=}}
| |
| − | {{tp|p=32475012|t=2020. Testing for SARS-CoV-2: the day the world turned its attention to the clinical laboratory.|pdf=|usr=007}}
| |
| − | {{tp|p=32320539|t=2020. La Asociacion Catalana de Salud Laboral (@SCSL) ante el gran reto de la COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32469511|t=2020. Virus Detection: What Were We Doing before COVID-19 Changed the World?|pdf=|usr=008}}
| |
| − | {{tp|p=32395391|t=2020. Development of a rapid test kit for SARS-CoV-2: an example of product design.|pdf=|usr=008}}
| |
| − | {{tp|p=32490854|t=2020. A novel liquid biopsy-based approach for highly specific cancer diagnostics: mitigating false responses in assaying patient plasma-derived circulating microRNAs through combined SERS and plasmon-enhanced fluorescence analyses.|pdf=|usr=008}}
| |
| − | {{tp|p=32452225|t=2020. Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era.|pdf=|usr=008}}
| |
| − | {{tp|p=32504943|t=2020. The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing.|pdf=|usr=008}}
| |
| − | {{tp|p=32473233|t=2020. Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive.|pdf=|usr=008}}
| |
| − | {{tp|p=32496708|t=2020. COVID-19 : quelle place, aujourd'hui, pour les tests serologiques ?|pdf=|usr=008}}
| |
| − |
| |
| − | ===009===
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32434518|t=2020. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.|pdf=|usr=009}}
| |
| − | {{tp|p=32383793|t=2020. Lung Ultrasound and the COVID-19 "Pattern": Not All That Glitters Today Is Gold Tomorrow.|pdf=|usr=009}}
| |
| − | {{tp|p=32383781|t=2020. On Lung Ultrasound Patterns Specificity in the Management of COVID-19 Patients.|pdf=|usr=009}}
| |
| − | {{tp|p=32395910|t=2020. Contrast-Enhanced Ultrasound in Patients With COVID-19: Pneumonia, Acute Respiratory Distress Syndrome, or Something Else?|pdf=|usr=009}}
| |
| − | {{tp|p=32227492|t=2020. Proposal for International Standardization of the Use of Lung Ultrasound for Patients With COVID-19: A Simple, Quantitative, Reproducible Method.|pdf=|usr=009}}
| |
| − | {{tp|p=32513550|t=2020. Diagnosis of Asymptomatic COVID-19 Infection in a Patient Referred for CT Lung Biopsy.|pdf=|usr=009}}
| |
| − | {{tp|p=32445875|t=2020. Ion torrent-based nasopharyngeal swab metatranscriptomics in COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32421144|t=2020. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.|pdf=|usr=009}}
| |
| − | {{tp|p=32310815|t=2020. Detection of SARS-CoV-2 RNA and Antibodies in Diverse Samples: Protocol to Validate the Sufficiency of Provider-Observed, Home-Collected Blood, Saliva, and Oropharyngeal Samples.|pdf=|usr=009}}
| |
| − | {{tp|p=32533391|t=2020. Study on the dynamic change law and correlation between CT imaging manifestations and cellular immunity of 2019 novel coronavirus disease.|pdf=|usr=009}}
| |
| − | {{tp|p=32529815|t=2020. Assessment of the Severity of Coronavirus Disease: Quantitative Computed Tomography Parameters versus Semiquantitative Visual Score.|pdf=|usr=009}}
| |
| − | {{tp|p=32410416|t=2020. Rapidly Progressive COVID-19 Pneumonia: What Radiologists Should Do.|pdf=|usr=009}}
| |
| − | {{tp|p=32410413|t=2020. Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia.|pdf=|usr=009}}
| |
| − | {{tp|p=32410412|t=2020. Association between Initial Chest CT or Clinical Features and Clinical Course in Patients with Coronavirus Disease 2019 Pneumonia.|pdf=|usr=009}}
| |
| − | {{tp|p=32524793|t=2020. COVID-19 Carrier or Pneumonia: Positive Real-Time Reverse-Transcriptase Polymerase Chain Reaction but Negative or Positive Chest CT Results.|pdf=|usr=009}}
| |
| − | {{tp|p=32524792|t=2020. Early CT Findings of Coronavirus Disease 2019 (COVID-19) in Asymptomatic Children: A Single-Center Experience.|pdf=|usr=009}}
| |
| − | {{tp|p=32524786|t=2020. CT Quantitative Analysis and Its Relationship with Clinical Features for Assessing the Severity of Patients with COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32373786|t=2020. Cautions about radiologic diagnosis of COVID-19 infection driven by artificial intelligence.|pdf=|usr=009}}
| |
| − | {{tp|p=32473662|t=2020. Implication of SARS-CoV-2 evolution in the sensitivity of RT-qPCR diagnostic assays.|pdf=|usr=009}}
| |
| − | {{tp|p=32445709|t=2020. RT-PCR for SARS-CoV-2: quantitative versus qualitative.|pdf=|usr=009}}
| |
| − | {{tp|p=32422197|t=2020. Who is most likely to be infected with SARS-CoV-2?|pdf=|usr=009}}
| |
| − | {{tp|p=32311327|t=2020. Rural areas at risk during COVID-19 pandemic.|pdf=|usr=009}}
| |
| − | {{tp|p=32445713|t=2020. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation.|pdf=|usr=009}}
| |
| − | {{tp|p=32479792|t=2020. Testing for COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32437649|t=2020. Challenges in the interpretation and application of typical imaging features of COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32526509|t=2020. Could MEFV mutation carriage status have a protective role for COVID-19 pandemic?|pdf=|usr=009}}
| |
| − | {{tp|p=32425648|t=2020. A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients.|pdf=|usr=009}}
| |
| − | {{tp|p=32425334|t=2020. Sequence mismatch in PCR probes may mask the COVID-19 detection in Nepal.|pdf=|usr=009}}
| |
| − | {{tp|p=32529418|t=2020. The Potential Role of Smartphone-Based Microfluidic Systems for Rapid Detection of COVID-19 Using Saliva Specimen.|pdf=|usr=009}}
| |
| − | {{tp|p=32379456|t=2020. Emerging Biomolecular Testing to Assess the Risk of Mortality from COVID-19 Infection.|pdf=|usr=009}}
| |
| − | {{tp|p=32376571|t=2020. [Effect of heat inactivation of blood samples on the efficacy of three detection methods of SARS-CoV-2 antibodies].|pdf=|usr=009}}
| |
| − | {{tp|p=32518804|t=2020. Correlation Between Chest CT Findings and Clinical Features of 211 COVID-19 Suspected Patients in Wuhan, China.|pdf=|usr=009}}
| |
| − | {{tp|p=32410825|t=2020. How to increase the SARS-CoV-2 detection rate through the nasopharyngeal swab?|pdf=|usr=009}}
| |
| − | {{tp|p=32528619|t=2020. Leveraging polymerase chain reaction technique (GeneXpert) to upscaling testing capacity for SARS-CoV-2 (COVID-19) in Nigeria: a game changer.|pdf=|usr=009}}
| |
| − | {{tp|p=32450346|t=2020. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications.|pdf=|usr=009}}
| |
| − | {{tp|p=32530929|t=2020. Rapid detection of novel coronavirus/Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by reverse transcription-loop-mediated isothermal amplification.|pdf=|usr=009}}
| |
| − | {{tp|p=32504802|t=2020. Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays.|pdf=|usr=009}}
| |
| − | {{tp|p=32411942|t=2020. Covid-19: round and oval areas of ground-glass opacity.|pdf=|usr=009}}
| |
| − | {{tp|p=32407516|t=2020. Response to letter to the editor: "Lung Ultrasound early detection and monitoring in Covid-19 Pneumonia: fact and fiction".|pdf=|usr=009}}
| |
| − | {{tp|p=32407487|t=2020. Lung Ultrasound early detection and monitoring in Covid-19 Pneumonia: fact and fiction.|pdf=|usr=009}}
| |
| − | {{tp|p=32489938|t=2020. Radiological follow-up of twelve COVID-19 patients with initially normal chest CT.|pdf=|usr=009}}
| |
| − | {{tp|p=32489937|t=2020. Should computed tomography (CT) be used as a screening or follow-up tool for asymptomatic patients with SARS-CoV-2 infection?|pdf=|usr=009}}
| |
| − | {{tp|p=32489936|t=2020. Computed tomography (CT) intestinal alterations of Coronavirus Disease 2019 (COVID-19) from the imaging perspective: a case description.|pdf=|usr=009}}
| |
| − | {{tp|p=32489931|t=2020. Early minimal lesions of COVID-19 pneumonia with interstitial lung abnormality: a case description.|pdf=|usr=009}}
| |
| − | {{tp|p=32489929|t=2020. A systematic review of chest imaging findings in COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32410816|t=2020. A case series of chest imaging manifestation of COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32423842|t=2020. False negative chest X-Rays in patients affected by COVID-19 pneumonia and corresponding chest CT findings.|pdf=|usr=009}}
| |
| − | {{tp|p=32406420|t=2020. High-resolution CT features of the COVID-19 infection in Nanchong City: Initial and follow-up changes among different clinical types.|pdf=|usr=009}}
| |
| − | {{tp|p=32399481|t=2020. Computed tomography findings in a case of coronavirus disease 2019.|pdf=|usr=009}}
| |
| − | {{tp|p=32519256|t=2020. Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: findings and correlation with clinical outcome.|pdf=|usr=009}}
| |
| − | {{tp|p=32500510|t=2020. Radiological management of COVID-19: structure your diagnostic path to guarantee a safe path.|pdf=|usr=009}}
| |
| − | {{tp|p=32500509|t=2020. Chest CT features of coronavirus disease 2019 (COVID-19) pneumonia: key points for radiologists.|pdf=|usr=009}}
| |
| − | {{tp|p=32515676|t=2020. Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series.|pdf=|usr=009}}
| |
| − | {{tp|p=32216718|t=2020. Chest Radiograph Findings in Asymptomatic and Minimally Symptomatic Quarantined Patients in Codogno, Italy during COVID-19 Pandemic.|pdf=|usr=009}}
| |
| − | {{tp|p=32447034|t=2020. The simulation-CT: Radiotherapy's useful tool in the race against COVID-19 pandemic. A serendipity approach.|pdf=|usr=009}}
| |
| − | {{tp|p=32469732|t=2020. Chest X-ray features of SARS-CoV-2 in the emergency department: a multicenter experience from northern Italian hospitals.|pdf=|usr=009}}
| |
| − | {{tp|p=32527255|t=2020. Predictors of fatality including radiographic findings in adults with COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32406576|t=2020. Serum amyloid A is a predictor for prognosis of COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32520136|t=2020. COVID-19: the virus in the control of culture?|pdf=|usr=009}}
| |
| − | {{tp|p=32520135|t=2020. A brief history of medical uniforms: from ancient history to the COVID-19 time.|pdf=|usr=009}}
| |
| − | {{tp|p=32419706|t=2020. Guia basica ecografia pulmonar y COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32426303|t=2020. DIAGNOSTICO DE NEUMONIA COVID 19 EN PACIENTES ASINTOMATICOS TRAS LA REALIZACION DE UN PET-TC ONCOLOGICO.|pdf=|usr=009}}
| |
| − | {{tp|p=32449374|t=2020. Laboratory findings of COVID-19: a systematic review and meta-analysis.|pdf=|usr=009}}
| |
| − | {{tp|p=32347067|t=2020. [Optimization of a fluorescent qPCR detection for RNA of SARS-CoV-2].|pdf=|usr=009}}
| |
| − | {{tp|p=32395897|t=2020. Recent progress on the diagnosis of 2019 Novel Coronavirus.|pdf=|usr=009}}
| |
| − | {{tp|p=32534208|t=2020. Serologic testing of coronaviruses from MERS-CoV to SARS-CoV-2: Learning from the past and anticipating the future.|pdf=|usr=009}}
| |
| − | {{tp|p=32419875|t=2020. Antikorpertests bei COVID-19 - Was uns die Ergebnisse sagen.|pdf=|usr=009}}
| |
